Control of p53 ubiquitination and nuclear export by MDM2 and ARF

被引：0

作者：

Zhang, YP

Xiong, Y ^{[1
]}

机构：

[1] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

[2] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA

[3] Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA

来源：

CELL GROWTH & DIFFERENTIATION | 2001年 / 12卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

p53 and ARF-INK4a are the two most frequently altered loci in human tumors. The activity of p53 protein is inhibited during normal cell growth by the proto-oncoprotein MDM2 through either repression of p53-mediated transcription in the nucleus or proteasomal degradation of p53 protein in the cytoplasm. Responding to oncogenic signal-activated cell hyperproliferation, ARF-mediated antagonism of MDM2 inhibition results in p53 becoming active and its protein levels rising. The biochemical mechanisms of ubiquitination and nuclear export that underlie the functions of ARF and MDM2 in p53 control continue to emerge.

引用

页码：175 / 186

页数：12

共 50 条

[31] Targeted Molecular Therapy for Neuroblastoma: The ARF/MDM2/p53 Axis
Kim, Eugene
Shohet, Jason
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (22): : 1527 - 1529
[32] ARF function does not require p53 stabilization or Mdm2 relocalization
Korgaonkar, C
Zhao, L
Modestou, M
Quelle, DE
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (01) : 196 - 206
[33] MDM2-dependent ubiquitination of nuclear and cytoplasmic P53
Yu, ZK
Geyer, RK
Maki, CG
ONCOGENE, 2000, 19 (51) : 5892 - 5897
[34] Downregulation of MDM2 stabilizes p53 by inhibiting p53 ubiquitination in response to specific alkylating agents
Inoue, T
Geyer, RK
Yu, ZK
Maki, CG
FEBS LETTERS, 2001, 490 (03) : 196 - 201
[35] P53 Mdm2 Inhibitors
Khoury, Kareem
Doemling, Alex
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678
[36] MDM2与p53
金晶
刘耕陶
癌症, 2001, (06) : 663 - 666
[37] Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53
Zhang, YP
Xiong, Y
MOLECULAR CELL, 1999, 3 (05) : 579 - 591
[38] MDM2 and BCL-2: to p53 or not to p53?
Wang, Eunice S.
BLOOD, 2023, 141 (11) : 1237 - 1238
[39] Binding of an inhibitor of the p53/MDM2 interaction to MDM2
Duncan, SJ
Cooper, MA
Williams, DH
CHEMICAL COMMUNICATIONS, 2003, (03) : 316 - 317
[40] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
Christine Wasylyk
Roberto Salvi
Manuela Argentini
Christine Dureuil
Isabelle Delumeau
Joseph Abecassis
Laurent Debussche
Bohdan Wasylyk
Oncogene, 1999, 18 : 1921 - 1934

← 1 2 3 4 5 →